These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 11551138)
1. Major apolipoprotein B-100 mutations in lipoprotein metabolism and atherosclerosis. Vrablík M; Ceska R; Horínek A Physiol Res; 2001; 50(4):337-43. PubMed ID: 11551138 [TBL] [Abstract][Full Text] [Related]
2. Rare and common mutations in hyperlipidemia and atherosclerosis. With special reference to familial defective apolipoprotein B-100. Tybjaerg-Hansen A Scand J Clin Lab Invest Suppl; 1995; 220():57-76. PubMed ID: 7652481 [TBL] [Abstract][Full Text] [Related]
3. Lipid disorders and mutations in the APOB gene. Whitfield AJ; Barrett PH; van Bockxmeer FM; Burnett JR Clin Chem; 2004 Oct; 50(10):1725-32. PubMed ID: 15308601 [TBL] [Abstract][Full Text] [Related]
4. Familial defective apolipoprotein B-100: detection and haplotype analysis of the Arg(3500)-->Gln mutation in hyperlipidemic Chinese. Teng YN; Pan JP; Chou SC; Tai DY; Lee-Chen GJ Atherosclerosis; 2000 Oct; 152(2):385-90. PubMed ID: 10998466 [TBL] [Abstract][Full Text] [Related]
5. Atherosclerosis: another protein misfolding disease? Ursini F; Davies KJ; Maiorino M; Parasassi T; Sevanian A Trends Mol Med; 2002 Aug; 8(8):370-4. PubMed ID: 12127722 [TBL] [Abstract][Full Text] [Related]
6. The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds. Pullinger CR; Gaffney D; Gutierrez MM; Malloy MJ; Schumaker VN; Packard CJ; Kane JP J Lipid Res; 1999 Feb; 40(2):318-27. PubMed ID: 9925662 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. Olofsson SO; Borèn J J Intern Med; 2005 Nov; 258(5):395-410. PubMed ID: 16238675 [TBL] [Abstract][Full Text] [Related]
8. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187 [TBL] [Abstract][Full Text] [Related]
9. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100. Gabel BR; Koschinsky ML Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051 [TBL] [Abstract][Full Text] [Related]
10. A new but frequent mutation of apoB-100-apoB His3543Tyr. Soufi M; Sattler AM; Maerz W; Starke A; Herzum M; Maisch B; Schaefer JR Atherosclerosis; 2004 May; 174(1):11-6. PubMed ID: 15135245 [TBL] [Abstract][Full Text] [Related]
11. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice. Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172 [TBL] [Abstract][Full Text] [Related]
12. Detection of the apolipoprotein B-100 arg(3500) > gl mutation in familial defective apoB-100 by temperature-gradient gel electrophoresis. Koch M; Pfohl M; Enderle M; Schnauder G; Seif FJ Z Gastroenterol; 1996 Jun; 34 Suppl 3():16-8. PubMed ID: 8767448 [TBL] [Abstract][Full Text] [Related]
13. Detection of familial defective apoB (FDB) mutations in hypercholesterolemic children and adolescents by denaturing high performance liquid chromatography (DHPLC). Nelken J; Meshkani R; Chahal N; McCrindle B; Adeli K Clin Biochem; 2008 Apr; 41(6):395-9. PubMed ID: 18222178 [TBL] [Abstract][Full Text] [Related]
15. [Genetic variation in the apolipoprotein B gene]. Vedie B; Myara I; Jeunemaitre X; Moatti N Ann Genet; 1995; 38(4):187-201. PubMed ID: 8629806 [TBL] [Abstract][Full Text] [Related]
16. The influence of apolipoprotein B and E gene polymorphisms on the response to simvastatin therapy in patients with hyperlipidemia. Ye P; Shang Y; Ding X Chin Med Sci J; 2003 Mar; 18(1):9-13. PubMed ID: 12901521 [TBL] [Abstract][Full Text] [Related]
18. Hammerhead ribozyme as a therapeutic agent for hyperlipidemia: production of truncated apolipoprotein B and hypolipidemic effects in a dyslipidemia murine model. Enjoji M; Wang F; Nakamuta M; Chan L; Teng BB Hum Gene Ther; 2000 Nov; 11(17):2415-30. PubMed ID: 11096445 [TBL] [Abstract][Full Text] [Related]
19. Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice. Wouters K; Shiri-Sverdlov R; van Gorp PJ; van Bilsen M; Hofker MH Clin Chem Lab Med; 2005; 43(5):470-9. PubMed ID: 15899668 [TBL] [Abstract][Full Text] [Related]